从更长远的视角看待新冠疫情。
Taking the Longer View of COVID-19.
作者信息
Chabner Bruce A
机构信息
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Oncologist. 2020 Jun;25(6):455-457. doi: 10.1634/theoncologist.2020-0313. Epub 2020 Apr 27.
Abstract
What are the prospects for dealing with COVID‐19 more effectively in the future? This editorial addresses the question from the perspective of long‐term control of coronavirus infection.
摘要
未来更有效地应对新冠病毒肺炎（COVID-19）的前景如何？这篇社论从冠状病毒感染的长期控制角度探讨了这个问题。
相似文献
1
Taking the Longer View of COVID-19.从更长远的视角看待新冠疫情。
Oncologist. 2020 Jun;25(6):455-457. doi: 10.1634/theoncologist.2020-0313. Epub 2020 Apr 27.
2
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.新冠病毒肺炎患者短期使用羟氯喹和阿奇霉素的经验及其对QTc趋势的影响
J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19.羟氯喹和阿奇霉素作为新型冠状病毒肺炎的一种治疗方法。
Intern Emerg Med. 2020 Aug;15(5):841-843. doi: 10.1007/s11739-020-02388-y. Epub 2020 May 30.
4
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.阿奇霉素与 SARS-CoV-2 感染：我们现在在哪里，以及我们将走向何方。
J Glob Antimicrob Resist. 2020 Sep;22:680-684. doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1.
5
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".没有证据表明用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗有临床益处：对《用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗：法国马赛1061例回顾性分析》的评论
Travel Med Infect Dis. 2020 Jul-Aug;36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3.
6
Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.用于治疗新冠病毒病的羟氯喹——当疫情发展速度超过研究速度时
Int J Cardiol. 2020 Oct 1;316:285-286. doi: 10.1016/j.ijcard.2020.05.079. Epub 2020 May 29.
7
Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?用于治疗COVID-19的羟氯喹啉-阿奇霉素——合理还是危险？
Travel Med Infect Dis. 2020 May-Jun;35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30.
8
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.在新型冠状病毒肺炎疫情背景下羟氯喹及其与阿奇霉素联合使用的安全性：比利时一家三级中心的临床经验
Travel Med Infect Dis. 2020 Jul-Aug;36:101788. doi: 10.1016/j.tmaid.2020.101788. Epub 2020 Jun 12.
9
Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.羟氯喹在新冠病毒病中的应用：重视统计学以关爱患者。
Int J Infect Dis. 2020 Oct;99:324. doi: 10.1016/j.ijid.2020.07.079. Epub 2020 Aug 6.
10
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.羟氯喹、2019冠状病毒病与QT间期延长
JAMA Cardiol. 2020 Sep 1;5(9):986-987. doi: 10.1001/jamacardio.2020.1782.
引用本文的文献
1
Challenges faced in the cancer diagnosis and management-COVID-19 pandemic and beyond-Lessons for future.癌症诊断与管理面临的挑战——新冠疫情及之后——对未来的启示
Heliyon. 2022 Dec 5;8(12):e12091. doi: 10.1016/j.heliyon.2022.e12091. eCollection 2022 Dec.
2
Quick overview of diagnostic kits and smartphone apps for urologists during the COVID-19 pandemic: a narrative review.COVID-19大流行期间泌尿外科医生使用的诊断试剂盒和智能手机应用程序概述：一篇叙述性综述
Transl Androl Urol. 2021 Feb;10(2):939-953. doi: 10.21037/tau-20-1042.
3
Perspectives of cancer patients and their health during the COVID-19 pandemic.癌症患者及其在 COVID-19 大流行期间的健康状况透视。
PLoS One. 2020 Oct 30;15(10):e0241741. doi: 10.1371/journal.pone.0241741. eCollection 2020.
4
Results of the Survey Conducted Among Caribbean Physicians on a Zoom Meeting Discussing the Article "A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group".对在一次关于文章“在新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组”的 Zoom 会议上讨论的加勒比医生进行的调查结果。
Oncologist. 2020 Dec;25(12):e2024-e2028. doi: 10.1002/onco.13556. Epub 2020 Oct 29.
5
SARS-CoV-2 and cancer: Are they really partners in crime?SARS-CoV-2 与癌症：它们真的是同谋吗？
Cancer Treat Rev. 2020 Sep;89:102068. doi: 10.1016/j.ctrv.2020.102068. Epub 2020 Jul 11.
本文引用的文献
1
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
2
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.一种口服生物利用度的广谱抗病毒药物可抑制人呼吸道上皮细胞培养中的 SARS-CoV-2 病毒和小鼠中的多种冠状病毒。
Sci Transl Med. 2020 Apr 29;12(541). doi: 10.1126/scitranslmed.abb5883. Epub 2020 Apr 6.
3
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
4
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
5
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
6
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.羟氯喹啉是氯喹毒性较低的衍生物，在体外可有效抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
Zotero 插件